BIO Double Helix Sponsor
Sponsors

Company Profile

Akebia Therapeutics

Drug Development
Cardiovascular Disease
Hematology

10151 Carver Road,
Suite 205
Cincinnati, OH 45242
USA
www.akebia.com 		Incorporated in 2007
3 Employees 		Privately Held

This Year's Highlights

  • Closed on Seed Round of financing in May 2007.
  • Two issued patents were added to licensing deal from Procter & Gamble at no additional cost to Akebia.
  • Converted four provisional patent filings to statutory filings covering primary drug candidate compounds on Akebia's two major programs.

Anticipated Highlights

  • Final data supported drug lead selection will be completed by November 07.
  • GMP synthesis and assembly of IND data will begin on two lead compounds on two distinct programs in first Quarter of 2008.
  • First industry partnership will be initiated on a specialized drug use application within one of Akebia's programs by first Quarter 2008.

Corporate Mission

Develop and commercialize drugs for major unmet needs in cardiovascular, peripheral vascular and hematological disease areas.